IMR Press / FBL / Volume 11 / Issue 3 / DOI: 10.2741/1984

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Identification of an octamer-binding site controlling the activity of the small breast epithelial mucin gene promoter
Show Less
1 Department of Pathology, University of Manitoba, 770 Bannatyne Avenue, Winnipeg R3E 0W3, Manitoba, Canada
2 Department of Biochemistry and Medical Genetics, University of Manitoba, 770 Bannatyne Avenue, Winnipeg R3E 0W3, Manitoba, Canada
3 Department of Physiology, Michigan State University, East Lansing, MI 48824, USA
Front. Biosci. (Landmark Ed) 2006, 11(3), 2483–2495; https://doi.org/10.2741/1984
Published: 1 September 2006
Abstract

e human small breast epithelial mucin (SBEM) gene has been identified as being preferentially expressed in mammary epithelial cells and over-expressed in breast tumors. In this report, we have characterized the promoter of SBEM gene in order to identify sequences responsible for this strong mammary expression. A series of SBEM promoter/luciferase constructs were transiently transfected into both breast (MCF-7, BT-20) and non-breast (HeLa and HepG2) cell lines. In addition to the minimal promoter and to a repressor region, we have identified an 87-bp sequence (-357/-270) driving a strong breast-specific expression. Site-directed mutagenesis of a putative octamer-binding transcription factor binding site located within this latter region led to a strong decrease of the transcriptional activity of the SBEM promoter. Furthermore, transient over-expression of Oct1 and Oct2 not only increased SBEM promoter reporter activity, but also enhanced endogenous SBEM mRNA level. Overall, the data suggest that octamer-binding transcription factors participate in the strong expression of SBEM gene in breast tissues. Clarifying the SBEM gene regulation will help to dissect mechanisms underlying transcription of normal breast and breast cancer-associated genes.

Keywords
Breast cancer
Breast-specific
Enhancer
Octamer-binding transcription factor
Promoter
SBEM
Share
Back to top